The necessity to develop drugs against parasitic diseases
This review focuses on the most significant trends in the development of drugs for the treatment of malaria, African sleeping sickness and toxoplasmosis. In the case of malaria, those include new fixed-dose artemisinin combinations, antifolates and new targets in the apicoplast of Plasmodium falcipa...
Gespeichert in:
| Veröffentlicht in: | Pharmazie 2002-11, Vol.57 (11), p.723-728 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 728 |
|---|---|
| container_issue | 11 |
| container_start_page | 723 |
| container_title | Pharmazie |
| container_volume | 57 |
| creator | KAISER, A GOTTWALD, A WIERSCH, C MAIER, W SEITZ, H. M |
| description | This review focuses on the most significant trends in the development of drugs for the treatment of malaria, African sleeping sickness and toxoplasmosis. In the case of malaria, those include new fixed-dose artemisinin combinations, antifolates and new targets in the apicoplast of Plasmodium falciparum. Targets in the treatment of trypanosomiasis are the biosynthesis of glycosylphosphatidylinositol and enzymes involved in the biosynthesis of trypanothione. Efforts to develop a vaccine against toxoplasmosis are discussed as well. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72857045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72857045</sourcerecordid><originalsourceid>FETCH-LOGICAL-p237t-6465edc63a12e348cf54e77018f46873a0d48162f6027260b274ae1b43236b383</originalsourceid><addsrcrecordid>eNpFz01Lw0AUheFZKLZW_4LMRneBmbmTmclSil9QcFPX4WZyU0fSJOYmQv-9BStdnc3DgfdCLJUCnXlt7UJcM38pZZxx4UostHFaGw9LUWw_SXYUiTlNBzn1sqYfavtB1uO8Y4k7TB1PcsARjyJFWScmZOIbcdlgy3R72pX4eH7arl-zzfvL2_pxkw0G_JQ563KqowPUhsCG2OSWvFc6NNYFD6hqG7QzjVPGG6cq4y2SriwYcBUEWImHv99h7L9n4qncJ47UtthRP3PpTci9svkR3p3gXO2pLocx7XE8lP-xR3B_AsgR22bELiY-OyiKQoODX8LLWo4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72857045</pqid></control><display><type>article</type><title>The necessity to develop drugs against parasitic diseases</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>KAISER, A ; GOTTWALD, A ; WIERSCH, C ; MAIER, W ; SEITZ, H. M</creator><creatorcontrib>KAISER, A ; GOTTWALD, A ; WIERSCH, C ; MAIER, W ; SEITZ, H. M</creatorcontrib><description>This review focuses on the most significant trends in the development of drugs for the treatment of malaria, African sleeping sickness and toxoplasmosis. In the case of malaria, those include new fixed-dose artemisinin combinations, antifolates and new targets in the apicoplast of Plasmodium falciparum. Targets in the treatment of trypanosomiasis are the biosynthesis of glycosylphosphatidylinositol and enzymes involved in the biosynthesis of trypanothione. Efforts to develop a vaccine against toxoplasmosis are discussed as well.</description><identifier>ISSN: 0031-7144</identifier><identifier>PMID: 12611273</identifier><identifier>CODEN: PHARAT</identifier><language>eng</language><publisher>Eschborn: Govi</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials - therapeutic use ; Antiparasitic agents ; Biological and medical sciences ; Humans ; Malaria - drug therapy ; Malaria - epidemiology ; Medical sciences ; Parasitic Diseases - drug therapy ; Pharmacology. Drug treatments ; Toxoplasmosis - prevention & control ; Trypanosomiasis - drug therapy ; Vaccines</subject><ispartof>Pharmazie, 2002-11, Vol.57 (11), p.723-728</ispartof><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13999136$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12611273$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAISER, A</creatorcontrib><creatorcontrib>GOTTWALD, A</creatorcontrib><creatorcontrib>WIERSCH, C</creatorcontrib><creatorcontrib>MAIER, W</creatorcontrib><creatorcontrib>SEITZ, H. M</creatorcontrib><title>The necessity to develop drugs against parasitic diseases</title><title>Pharmazie</title><addtitle>Pharmazie</addtitle><description>This review focuses on the most significant trends in the development of drugs for the treatment of malaria, African sleeping sickness and toxoplasmosis. In the case of malaria, those include new fixed-dose artemisinin combinations, antifolates and new targets in the apicoplast of Plasmodium falciparum. Targets in the treatment of trypanosomiasis are the biosynthesis of glycosylphosphatidylinositol and enzymes involved in the biosynthesis of trypanothione. Efforts to develop a vaccine against toxoplasmosis are discussed as well.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials - therapeutic use</subject><subject>Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Humans</subject><subject>Malaria - drug therapy</subject><subject>Malaria - epidemiology</subject><subject>Medical sciences</subject><subject>Parasitic Diseases - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Toxoplasmosis - prevention & control</subject><subject>Trypanosomiasis - drug therapy</subject><subject>Vaccines</subject><issn>0031-7144</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFz01Lw0AUheFZKLZW_4LMRneBmbmTmclSil9QcFPX4WZyU0fSJOYmQv-9BStdnc3DgfdCLJUCnXlt7UJcM38pZZxx4UostHFaGw9LUWw_SXYUiTlNBzn1sqYfavtB1uO8Y4k7TB1PcsARjyJFWScmZOIbcdlgy3R72pX4eH7arl-zzfvL2_pxkw0G_JQ563KqowPUhsCG2OSWvFc6NNYFD6hqG7QzjVPGG6cq4y2SriwYcBUEWImHv99h7L9n4qncJ47UtthRP3PpTci9svkR3p3gXO2pLocx7XE8lP-xR3B_AsgR22bELiY-OyiKQoODX8LLWo4</recordid><startdate>20021101</startdate><enddate>20021101</enddate><creator>KAISER, A</creator><creator>GOTTWALD, A</creator><creator>WIERSCH, C</creator><creator>MAIER, W</creator><creator>SEITZ, H. M</creator><general>Govi</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20021101</creationdate><title>The necessity to develop drugs against parasitic diseases</title><author>KAISER, A ; GOTTWALD, A ; WIERSCH, C ; MAIER, W ; SEITZ, H. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p237t-6465edc63a12e348cf54e77018f46873a0d48162f6027260b274ae1b43236b383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials - therapeutic use</topic><topic>Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Humans</topic><topic>Malaria - drug therapy</topic><topic>Malaria - epidemiology</topic><topic>Medical sciences</topic><topic>Parasitic Diseases - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Toxoplasmosis - prevention & control</topic><topic>Trypanosomiasis - drug therapy</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAISER, A</creatorcontrib><creatorcontrib>GOTTWALD, A</creatorcontrib><creatorcontrib>WIERSCH, C</creatorcontrib><creatorcontrib>MAIER, W</creatorcontrib><creatorcontrib>SEITZ, H. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmazie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAISER, A</au><au>GOTTWALD, A</au><au>WIERSCH, C</au><au>MAIER, W</au><au>SEITZ, H. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The necessity to develop drugs against parasitic diseases</atitle><jtitle>Pharmazie</jtitle><addtitle>Pharmazie</addtitle><date>2002-11-01</date><risdate>2002</risdate><volume>57</volume><issue>11</issue><spage>723</spage><epage>728</epage><pages>723-728</pages><issn>0031-7144</issn><coden>PHARAT</coden><abstract>This review focuses on the most significant trends in the development of drugs for the treatment of malaria, African sleeping sickness and toxoplasmosis. In the case of malaria, those include new fixed-dose artemisinin combinations, antifolates and new targets in the apicoplast of Plasmodium falciparum. Targets in the treatment of trypanosomiasis are the biosynthesis of glycosylphosphatidylinositol and enzymes involved in the biosynthesis of trypanothione. Efforts to develop a vaccine against toxoplasmosis are discussed as well.</abstract><cop>Eschborn</cop><pub>Govi</pub><pmid>12611273</pmid><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0031-7144 |
| ispartof | Pharmazie, 2002-11, Vol.57 (11), p.723-728 |
| issn | 0031-7144 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72857045 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Animals Antibiotics. Antiinfectious agents. Antiparasitic agents Antimalarials - therapeutic use Antiparasitic agents Biological and medical sciences Humans Malaria - drug therapy Malaria - epidemiology Medical sciences Parasitic Diseases - drug therapy Pharmacology. Drug treatments Toxoplasmosis - prevention & control Trypanosomiasis - drug therapy Vaccines |
| title | The necessity to develop drugs against parasitic diseases |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A42%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20necessity%20to%20develop%20drugs%20against%20parasitic%20diseases&rft.jtitle=Pharmazie&rft.au=KAISER,%20A&rft.date=2002-11-01&rft.volume=57&rft.issue=11&rft.spage=723&rft.epage=728&rft.pages=723-728&rft.issn=0031-7144&rft.coden=PHARAT&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72857045%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72857045&rft_id=info:pmid/12611273&rfr_iscdi=true |